AMCP webinar that described the impact of COVID-19 and associated mitigation measures strategies for patients with SUD and identify regulatory changes and innovations within SUD programs and reimbursement due to the COVID-19 pandemic.
Sponsored webinar that reviewed clinical and population measures for asthma control, guideline recommendations for management, and studies that show improved control using different methods.
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is a non-Hodgkin lymphoma subtype that varies patient by patient, with some having a highly aggressive disease course and others having indolent disease that progresses slowly over several years.
Partnership Forum: This forum identified challenges and payer needs related to the evidence for digital therapeutics. The forum explored the current market space for digital therapeutics including the evidence for the products, place in therapy, monitoring or utilization metrics and barriers that patients face in obtaining therapies.
